Literature DB >> 21828185

The P2Y(6) receptor stimulates bone resorption by osteoclasts.

Isabel R Orriss1, Ning Wang, Geoffrey Burnstock, Timothy R Arnett, Alison Gartland, Bernard Robaye, Jean-Marie Boeynaems.   

Abstract

Accumulating evidence indicates that extracellular nucleotides, signaling through P2 receptors, play a significant role in bone remodeling. Osteoclasts (the bone-resorbing cell) and osteoblasts (the bone-forming cell) display expression of the G protein-coupled P2Y(6) receptor, but the role of this receptor in modulating cell function is unclear. Here, we demonstrate that extracellular UDP, acting via P2Y(6) receptors, stimulates the formation of osteoclasts from precursor cells, while also enhancing the resorptive activity of mature osteoclasts. Furthermore, osteoclasts derived from P2Y(6) receptor-deficient (P2Y(6)R(-/-)) animals displayed defective function in vitro. Using dual energy x-ray absorptiometry scanning and microcomputed tomographic analysis we showed that P2Y(6)R(-/-) mice have increased bone mineral content, cortical bone volume, and cortical thickness in the long bones and spine, whereas trabecular bone parameters were unaffected. Histomorphometric analysis showed the perimeter of the bone occupied by osteoclasts on the endocortical and trabecular surfaces was decreased in P2Y(6)R(-/-) mice. Taken together these results show the P2Y(6) receptor may play an important role in the regulation of bone cell function in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828185     DOI: 10.1210/en.2011-1073

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

2.  Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro.

Authors:  Mark O R Hajjawi; Jessal J Patel; Michelangelo Corcelli; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2016-02-10       Impact factor: 3.765

3.  The PRKAA1/AMPKα1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML.

Authors:  Sandrine Obba; Zoheir Hizir; Laurent Boyer; Dorothée Selimoglu-Buet; Anja Pfeifer; Gregory Michel; Mohamed-Amine Hamouda; Diogo Gonçalvès; Michael Cerezo; Sandrine Marchetti; Stephane Rocchi; Nathalie Droin; Thomas Cluzeau; Guillaume Robert; Frederic Luciano; Bernard Robaye; Marc Foretz; Benoit Viollet; Laurence Legros; Eric Solary; Patrick Auberger; Arnaud Jacquel
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

4.  4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor.

Authors:  P Suresh Jayasekara; Matthew O Barrett; Christopher B Ball; Kyle A Brown; Eszter Kozma; Stefano Costanzi; Lucia Squarcialupi; Ramachandran Balasubramanian; Hiroshi Maruoka; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2013-05-30       Impact factor: 3.597

5.  Nucleotides modulate synoviocyte proliferation and osteoclast differentiation in macrophages with potential implications for rheumatoid arthritis.

Authors:  Sai Krishna Srimadh Bhagavatham; Vishnu Kannan; V M Datta Darshan; Venketesh Sivaramakrishnan
Journal:  3 Biotech       Date:  2021-11-19       Impact factor: 2.406

6.  Modulation of osteoblast differentiation and function by the P2X4 receptor.

Authors:  Isabel R Orriss; Bethan K Davies; Lucie E Bourne; Timothy R Arnett
Journal:  Purinergic Signal       Date:  2022-08-17       Impact factor: 3.950

7.  Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.

Authors:  Seung Ah Lee; Jin Hee Park; Soo Young Lee
Journal:  Mol Cells       Date:  2013-09-17       Impact factor: 5.034

8.  The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels.

Authors:  Andrea Brandao-Burch; Michelle L Key; Jessal J Patel; Timothy R Arnett; Isabel R Orriss
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-19       Impact factor: 5.555

Review 9.  Update of P2Y receptor pharmacology: IUPHAR Review 27.

Authors:  Kenneth A Jacobson; Esmerilda G Delicado; Christian Gachet; Charles Kennedy; Ivar von Kügelgen; Beibei Li; M Teresa Miras-Portugal; Ivana Novak; Torsten Schöneberg; Raquel Perez-Sen; Doreen Thor; Beili Wu; Zhenlin Yang; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 9.473

10.  Purinergic signalling in bone.

Authors:  Robin M H Rumney; Ning Wang; Ankita Agrawal; Alison Gartland
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.